Vaccines should be seen as a kind of foreign aid.
Academic rigour, journalistic flair
Articles on COVID vaccines
Displaying 41 - 60 of 78 articles
After a dispute with AstraZeneca, the European Commission is restricting access to vaccines made within its borders.
It's going to be a huge logistical challenge.
The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
A recommendation from a German vaccine advisory body not to give the AstraZeneca vaccine to people aged over 65 has caused concern. But we should interpret this advice with caution.
It's no secret many kids (and adults) don't like needles. But where needle phobia can be a barrier to vaccine acceptance, it's important to set your children up not to fear injections. Here's how.
Black people have understandable concerns about vaccines due to a history of racism.
Currently, we don’t have the legal infrastructure or public forums needed to address the spread of coronavirus misinformation in Australia. A new proposal could help change that.
We've gone from a novel virus to several COVID-19 vaccines in less than a year. Here's what we've learned from earlier vaccines to allow this to happen.
Australia is set to get the green light to roll out the Pfizer vaccine any day now. There is a complex process behind this.
CC BY-NC-ND13.3 MB (download)
Nigeria needs a coherent plan to get COVID-19 vaccines.
As the eradication of polio and the successful rollout of AIDS treatments have shown in the past, global cooperation in the face of COVID-19 is possible.
African leaders can make strategies to fight COVID-19 more accessible to the people.
With richer countries having bought up most of the leading western vaccines, others are looking to India, China and Russia for supplies.
Achieving high COVID-19 vaccine uptake among health workers will not only protect these critical staff members, it will also support high levels of uptake among the general public.
The best approach for protecting everyone’s health will require us to provide different vaccines to different people according to need and availability.
Despite the latest tweaks to border testing rules, the risk of imported infection remains very high. NZ's wider response needs upgrading —including reducing the large numbers of infected returnees.
With reports emerging of vaccine wastage across the world, medical supply chain experts explain why that's to be expected.
A waiver on some intellectual property rules at the WTO for COVID-19 vaccines would ensure more equitable access, but wouldn't solve all the problems facing developing countries.
COVID-19 vaccines could substantially reduce hospital admissions, but will be slower at freeing up space in intensive care.
Top contributors
-
Associate professor, UNSW
-
Stephen Duckett is a Friend of The Conversation.
Director, Health Program, Grattan Institute
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Senior Lecturer, The University of Queensland
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Professor of Veterinary Microbiology, University of Ibadan
-
Assistant Professor, General Practice, Bond University
-
Researcher, Walter and Eliza Hall Institute
-
Associate professor, La Trobe University
-
Lecturer, Media and Communication, UWA, University of Western Australia
-
Reader in Health Economics, Centre for Health Economics, University of York
-
Director and CEO, Burnet Institute
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Professor in Global Public Health and Director of the Mitchell Institute, Victoria University
-
Lecturer, University of Technology Sydney
